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Abstract
Background: Bloodstream infections in neonates and infants are life-threatening emergencies. Identification of the
common bacteria causing such infections and their susceptibility patterns will provide necessary information for
timely intervention. This study is aimed at determining the susceptibilities of bacterial etiological agents to
commonly-used antimicrobial agents for empirical treatment of suspected bacterial septicaemia in children.
Methods: This is a hospital based retrospective analysis of blood cultures from infants to children up to 14 years of
age with preliminary diagnosis of sepsis and admitted to the Neonatal Intensive Care Unit (NICU) and Paediatric
Wards of the Teaching Hospital Tamale from July 2011 to January 2012.
Results: Out of 331 blood specimens cultured, the prevalence of confirmed bacterial sepsis was 25.9% (86/331).
Point prevalence for confirmed cases from NICU was 44.4% (28/63) and 21.6% (58/268) from the Paediatric ward.
Gram positive cocci (GPC) were the predominant isolates with Coagulase positive (32.2%) and Coagulase-negative
(28.7%) Staphylococci accounting for 60.9% of the total isolates. Gram negative rods (GNR) comprised 39.1% of all
isolates with Klebsiella, E.coli and Salmonella being the most common organisms isolated. Klebsiella was the most
frequent GNR from the NICU and Salmonella typhi was predominantly isolated from the paediatric ward.
Acinetobacter showed 100.0% susceptibility to Ceftriaxone and Cefotaxime but was resistant (100.0%) to Ampicillin,
Tetracycline and Cotrimoxazole. Escherichia coli and Klebsiella were 80.0% and 91.0% susceptible to Ceftriaxone and
Cefotaxime respectively. Klebsiella species showed 8.3% susceptibility to Tetracycline but was resistant to Ampicillin
and Cotrimoxazole. Escherichia coli showed 40.0% susceptibility to Ampicillin, Chloramphenicol and Cotrimoxazole;
20.0% susceptibility to Tetracycline and 80.0% susceptible to Gentamicin and Cefuroxime. Coagulase negative
Staphylococci was susceptible to Gentamicin (72.0%) but Coagulase positive Staphylococci showed intermediate
sensitivity to Gentamicin (42.9%).
Conclusion: Coagulase Negative, Coagulase Positive Staphylococci, Salmonella and Klebsiella were the aetiological
agents of bloodstream infection among children at TTH. While gram-positive and gram-negative bacteria showed
low susceptibility to Ampicillin, Tetracycline and Cotrimoxazole, the GNR were susceptible to Gentamicin and third-
generation cephalosporins.
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Background
The World Health Organization (WHO) reported in 2005
that over 70 percent of deaths in children under age five
occur within the first year of life and 40 percent occur
within the first month of life [1]. The causes of death
according to the report were attributable to malnutrition
and infectious diseases [1]. In Ghana the estimated number
of deaths among children aged 1-59 months was 32,052,
while 22,672 deaths were estimated to have occurred
among children 0-27 days, with neonatal sepsis accounting
for 4,923 deaths in 2008 [2]. Sepsis is a blood stream infec-
tion usually caused by pathogenic bacteria with the diagno-
sis often beginning with clinical suspicion [3]. However, in
children the symptoms are often non-specific, and the
clinical course may be fulminant, quickly progressing to a
medical emergency that requires urgent attention [4,5].
The principal method of diagnosing sepsis is the isolation
of causative organisms from blood cultures [6]. In
industrialized countries Group B Streptococcus (GBS) and
Escherichia coli have been reported as the most frequent
bacterial etiological agents of neonatal and infant sepsis
[7,8]. While Escherichia coli and other gram-negative rods
(GNR) have been reported to be responsible for the high
morbidity and mortality rates among children in some
developing countries [9,10], sepsis among Ghanaian
children is predominantly caused by Staphylococcus aureus
and non-typhoid Salmonellae [11,12]. Blood culture and
antimicrobial susceptibility testing results are usually avail-
able between 48-72 hours after the specimen is obtained
and therefore initial antimicrobial treatment has been
usually empirical with the aim that the most likely
pathogens would be susceptible to the chosen drugs [5].
However, this initiative is undermined by the fact that the
spectrum of bacteria and their susceptibility patterns may
vary over time, depending on the prevailing conditions such
as patient population, antimicrobial drug usage and
healthcare worker’s infection control practices. If not
monitored, this could lead to inappropriate use of
antibiotics and a subsequent increase in antimicrobial
resistant organisms [13-15]. In order to guide empirical
therapy, this study reports on bacterial isolates and their
susceptibility to commonly-used antimicrobial agents in the
empirical treatment of suspected bacterial septicaemia in
children presenting at the Tamale Teaching Hospital.
Methods
Study period/site
This retrospective study was conducted at the Tamale
Teaching Hospital (TTH) from July 2011 to January
2012. TTH is a 340 bed complement hospital situated in
the Northern Region of Ghana. In addition to offering
clinical care to the inhabitants of Tamale and its
surrounding environ, it also serves as a referral hospital
to the two Upper regions (Upper East and Upper West)
of Ghana. The hospital runs six clinical departments
including Paediatrics. With a bed complement of 60, the
Paediatric ward receives admissions from the Children’s
Emergency Ward (CEW), reporting cases from home or
as referrals from other hospitals. The CEW serves as an
outpatient clinic to the surrounding population and sees
patients up to 14 years of age. The ward has 11 beds
for emergency stabilization and holds children for up
to 24 hours for treatment with onward admission to
the Pediatric ward when hospitalization becomes neces-
sary. All infants less than 30 days of age are admitted to
the Neonatal Intensive Care Unit (NICU) which has a bed
complement of 17. TTH is an affiliated teaching hospital
for the School of Medicine and Health Sciences, University
for Development Studies (UDS). Approval for the study
was obtained from the Research and Planning Unit for
Ethics of TTH.
Data extraction
Data comprising age, sex, bacterial isolates and their sus-
ceptibility reports recorded from July 2011 to January
2012 were extracted from the blood culture entry books
of the Bacteriology unit of the hospital’s Laboratory De-
partment. All cases of blood culture requested with a
preliminary diagnosis of sepsis from a newborn up to
14 years of age admitted at the NICU, children’s emer-




Blood specimens were taken into BD Ped culture broth
bottles (BD 7 Loveton Circle, Sparks Maryland USA) after
thorough cleaning of the venipuncture site and the rubber
cap of the bottle with 70% alcohol. The culture bottles were
then incubated at 35C in the BACTECW 9050 blood
culture system (BD 7 Loveton Circle, Sparks Maryland
USA) for 5 days after which negative indicating specimen
are discarded [16,17]. Positive indicated culture bottles were
removed and 1 ml of broth aseptically withdrawn from the
culture bottles using a sterile syringe and needle. Two
drops of the broth were inoculated onto MacConkey Agar,
Blood Agar (BA) and Chocolate Agar (CA) plates respec-
tively. The BA and CA plates were placed in candle extinc-
tion jars and incubated at 37C for 18 to 24 hours together
with the MacConkey plates.
Gram stain
Gram staining for bacterial identification was performed
on heat-fixed smears prepared from the remaining broth
following standard bacteriological protocol described
by [18].
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Bacterial identification
Only plates that showed homogenous colony appearance
were followed-up for bacterial identification. Conventional
identification methods based on characteristics such as
morphology, appearance in culture media, physiological
and biochemical properties were relied upon to properly
identify isolated organisms [18]. The BBL Crystal Auto
reader (BD 7 Loveton Circle, Sparks Maryland USA) was
employed where conventional methods for identification
were inconclusive. Tube coagulase was performed for
isolates of gram positive cocci in clusters [18,19].
Antimicrobial susceptibility tests were done using the
Kirby-Bauer disk diffusion method [20] and interpreted
according to the Clinical and Laboratory Standard Institute
(CLSI) criteria. Susceptibility testing was controlled with
American Type Culture Collection (ATCC) strains:
Staphylococcus aureus ATCC 25923, Escherichia coli ATCC
25922 and Pseudomonas aeruginosa ATCC 27853 [21].
Data analysis
Data retrieved were entered into Microsoft Excel and
analyzed using GraphPad PrismW Version 5.0 for
Windows (GraphPad Software, San Diego, CA, USA).
Descriptive statistics was employed to explain the general
distribution of data. Categorical variables were compared
using Chi-square test where appropriate. For all statistical




During the study period, spanning July 2011 to January
2012, NICU registered a total of 1074 admissions. The
paediatric ward registered a total of 3110 admissions, of
which 2537 were received from the Children’s Emergency
Ward (Institutional care report 2012). The median age of
infants with positive blood culture in NICU was 5 days
with that for children being 3 years.
Blood cultures
During the study period, a total of 331 blood cultures
with complete demographic and bacteriological data
were received. Two hundred and sixty-eight (81.0%)
were from the paediatric ward and 63 (19%) were from
NICU. Out of the 331 blood cultures, 97 (29.3%) were
flagged positive. Ten (10) of the positively flagged
samples were considered as being contaminated upon
the isolation of Corynebacterium species, Bacillus
species and Micrococcus species which were considered
as contaminants [22,23]. One positive sample vial was
indicative of the presence of yeast leaving 86 true positive
(pure culture) samples to be followed. The estimated
overall contamination rate was 3% with confirmed
bacterial sepsis rate being 26.0% (86/331).
Positive bacterial isolates stratified by ward
Of the 63 cultures submitted from the NICU, 28 (44%)
were positive out of which 15 (35%) cases were early
onset infections (less than 7 days of age) and 13 (42.8%)
cases were late onset infections (greater than 7 days of
age.) Of the 268 cultures submitted from the paediatric
ward, 58 (21.6%) were positive for bacterial pathogens.
Upon stratification into their gram reactions, 55
(64.0%) were gram-positive cocci (GPC) and 31(36.0%)
were gram-negative rods (GNR). Coagulase positive and
Coagulase-negative Staphylococci were the predominant
GPC isolates recovered from all the wards, accounting
for 32.2% and 28.7% of the total isolates respectively. For
the GNR’s, Klebsiella was the most frequent isolate
among the neonates and children from the paediatric
ward. Escherichia coli were recovered in similar
proportions across the wards with Salmonella typhi
being the major cause of bacterial sepsis in children
admitted to the paediatric ward. Streptococci and
Acinetobacter species were only rarely recovered from
NICU and the paediatric ward respectively (Table 1).
Antibiotic sensitivity profiles of isolated bacterial
pathogens
Table 2 shows the susceptibilities of the isolated pathogens
from the two units. Among the antimicrobials used, third-
generation cephalosporins (Ceftriaxone and Cefotaxime)
showed good activity against the GNR isolates. Salmonella
Table 1 Bacterial pathogens isolated from the two wards
NICU PAED TOTAL
(N = 63) (N = 268) (N = 331)
Pathogens EOS(%) LOS(%) n(%) n(%)
Gram positive cocci (GPC)
Coagulase Positive
Staphylococci
3(20.0) 5(38.5) 20(34.5) 28(32.2)
Coagulase Negative
Staphylococci
5(33.3) 5(38.5) 15(25.9) 25(28.7)
Streptococcus pneumoniae 0(0.0) 0(0.0) 1(1.7) 1(1.2)
β-haemolytic Streptococcus 0(0.0) 0(0.0) 1(1.7) 1(1.2)
Gram negative rods (GNR)
Klebsiella pneumoniae 2(13.3) 0(0.0) 4(6.9) 6(6.9)
Escherichia coli 1(6.7) 1(7.7) 4(6.9) 6(6.9)
Salmonella typhi 0(0.0) 0(0.0) 6(10.3) 6(6.9)
Klebsiella spp 2(13.3) 0(0.0) 4(6.9) 6(6.9)
Pseudomonas aeruginosa 0(0.0) 1(7.7) 2(3.4) 3(3.5)
Non-typhoidal Salmonella 1(6.7) 0(0.0) 1(1.7) 2(2.3)
Acinetobacter spp 1(6.7) 1(7.7) 0(0.0) 2(2.3)
Total isolates 15 13 58 86
NICU: Neonatal intensive care unit, PAED: Paediatric ward, EOS: Early onset, LOS
Late onset.
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and Acinetobacter showed 100.0% susceptibility, while
Escherichia coli and Klebsiella were 80.0% and 91.0%
susceptible to Ceftriaxone and Cefotaxime respectively.
Salmonella and Acinetobacter were 100.0% resistant to
Ampicillin, Tetracycline and Cotrimoxazole. Klebsiella
species showed 8.3% susceptibility to Tetracycline but
were 100.0% resistant to Ampicillin and Cotrimoxazole.
Escherichia coli showed variable susceptibility to the tested
antimicrobials with 40.0% susceptible to Ampicillin,
Chloramphenicol and Cotrimoxazole; 20.0% susceptible to
Tetracycline; and 80.0% susceptible to Gentamicin and
Cefuroxime. The susceptibility of Pseudomonas aeruginosa
to the commonly used antimicrobials, Gentamicin,
Ceftriaxone, and Cefotaxime, is as shown in Table 2. Levels
of susceptibility of the GPC to the available antimicrobials
also varied greatly. Most Coagulase positive Staphylococci
(96.4%) and the Coagulase negative Staphylococci (96.0%)
were resistant to Ampicillin and Penicillin. Coagulase nega-
tive Staphylococci was often sensitive to Gentamicin
(72.0%) but Coagulase positive Staphylococci had only
intermediate sensitivity to Gentamicin (42.9%) (Table 2).
Discussion
Bloodstream infection remains a major cause of morbi-
dity and prolonged hospital stay in children [24]. In
neonates and infants, it is a life-threatening emergency,
and therefore identifying the common bacteria and their
susceptibility patterns will provide information necessary
for timely intervention [25,26]. Unfortunately there is
limited information about the spectrum of pathogens
causing infection and their antibiotic susceptibility in
many under-resourced areas [27]. Over the six months
study period, this study showed a 25.9% positivity rate
for isolated bacterial pathogens. This could most likely
represent an under-estimation of the true prevalence of
bacterial septicaemia as many of the infants and children
cared for in NICU and the paediatric ward respectively
received empirical treatment with antibiotics before
blood was drawn for culture. Polage et al. [28] iterated
this fact in their study on laboratory use in Ghana where
they concluded that physician perception regarding the
value of diagnostic testing has been a major potential
barrier to laboratory use resulting in empiricism and
disproportionate antimicrobial administration. The esti-
mated positivity rate for isolated bacterial pathogens
from this study is however lower than rates found in
University of Calabar Teaching Hospital (48.9%) and
University of Port Harcourt Teaching Hospital (34.2%)
in Nigeria [29,30].
The spectrum of gram-negative bacteria responsible
for neonatal sepsis in this study is similar to that
reported by other authors [31-33] with the predominant
isolates being Klebsiella and Escherichia coli. Klebsiella
may be regarded as normal flora in many parts of the
body. They colonize the skin, pharynx, and the gastro-
intestinal tract. They may, however, be associated with
chorioamnionitis, urogenital infection or urinary tract
infection in the mother. Neonates could therefore
acquire these organisms before and/or during delivery
from their mothers with infections at the time of delivery
or shortly thereafter [34].
As reported in other studies [35,36], the GPC were the
predominant bacteria isolates in both early and late
onset sepsis from NICU. The high proportions of CoNS
isolated in both early onset (33.3%) and late onset
(38.5%) at the NICU gives a suggestion of CoNS as an
emerging pathogen in the unit [37]. However, the diag-
nosis of CoNS in bloodstream infections is problematic.
Generally, CoNS is not thought to be a cause of EOS,
although it has been reported in studies reviewing
organisms causing early infections [38,39]. Conversely,
CoNS is the predominant cause of LOS in low birth
weight infants and infants who have indwelling catheters
or other instrumentation [40,41]. The isolation of CoNS
in blood cultures is considered to be pathogenic if it is
obtained from at least two separate sites, a process
which may be difficult in infants [40]. Therefore the
combination of isolation of CoNS from the bloodstream
with clinical symptoms of neonatal infection may be the
best approach for determining pathogenicity of the
Table 2 Bacterial isolates and susceptibility patterns among study population
GEN CRX CHLO CTR CTX AMP TET COT PEN FLX ERY
Bacteria isolates N n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%)
Salmonella spp 8 - - 5(62.5) 8(100.0) 8(100.0) 0(0.0) 0(0.0) 0(0.0) - - -
Klebsiella spp 12 4(33.3) 1(8.3) 5(41.7) 11(91.7) 11(91.7) 0(0.0) 1(8.3) 0(0.0) - - -
Escherichia coli 6 4(66.7) 4(66.7) 2(33.3) 4(66.7) 4(66.7) 2(33.3) 1(16.7) 2(33.3) - - -
Acinetobacter spp 2 2(100.0) 0(0.0) 0(0.0) 2(100) 2(100.0) 0(0.0) 0(0.0) 0(0.0) - - -
Pseudomonas aeruginosa 3 1(33.3) - - 1(33.3) 1(33.3) - - - - - -
Coagulase negative Staphylococci 25 18(72.0) 14(56.0) - - - 1(4.0) 6(24.0) 5(20.0) 1(4.0) 10(40.0) 13(52.0)
Coagulase positive Staphylococci 28 12(42.9) 16(57.1) - - - 1(3.6) 2(25) 2(7.1) 1(3.6) 8(28.6) 10(35.7)
GEN –Gentamicin, CRX-Cefuroxime, CHLO-Chloramphenicol, CTR-Ceftriaxone, CTX- Cefotaxime, AMP-Ampicillin, TET- Tetracycline, COT-Cotrimoxazole, PEN- Penicillin,
FLX-Flucloxacillin, ERY- Erythromycin, (-) – Not done, Salmonella spp= Salmonella spp and Salmonella typhi, Klebsiella spp = Klebsiella spp and Klebsiella pneumoniae.
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CoNS [41,42]. Since CoNS is the predominant bacteria
colonizing the skin, it is very easy to contaminate the
blood culture during the process of venipuncture. The
optimal technique for obtaining blood cultures specifies
povidone-iodine or chlorhexidine as skin-cleansing
agents and venipuncture techniques that minimize
contamination by skin flora [41]. Generally, 70% alcohol
serves as the major cleansing agent of the skin in
resource-limited areas in view of perennial unavailability
of povidone and chlorhexidine in both the NICU and
paediatric wards. These factors suggest that the high
proportion of the CoNS isolated is more likely to be
contamination from the skin [26,43].
Consistent with other studies [44,45], Streptococcal
species were recovered infrequently from neonates with
early onset (EOS) in this study. There is an on-going
debate about the importance of GBS infections in sub-
Saharan Africa [46,47]. Although most studies report
that GBS infections are rare in Africa, studies in Malawi,
Kenya, South Africa and Zimbabwe report that maternal
colonization and EOS infections rates are similar to
those reported from the United States and Europe [48].
It has been hypothesized that the overwhelming nature
of the infection in the neonate with early death, a
predominantly out-born population, the infrequency of
obtaining blood cultures in sick infants, and the fastidi-
ous culture requirements to identify GBS might interfere
with its identification as a major pathogen in the neo-
natal period [48]. Other authors suggest that the cause
of EOS is gradually shifting from vertical transmission to
acquisition of infection from immediate exposure to
environment such as hands of health-care workers or
unclean delivery practices [44,45]. The yield of GBS from
blood cultures is greatly influenced by many factors such as
methodology of obtaining blood cultures, recent or
intrapartum antibiotic use, and requirement for specialized
media [49]. Interpretation of results from this study should
be done cautiously as most of these factors were not
factored into the inclusion criteria per the design of
the study.
In spite of the fact that late-onset (LOS) neonatal infec-
tion may occur through vertical transmission during
passage through the birth canal leading to colonization and,
later, to infection [50], the majority of the LOS in newborn
infants is usually hospital-acquired infection [26]. Although
some of the blood cultures from babies greater than seven
days of age were obtained from infants who had been
admitted to the NICU immediately after birth and then
became sick (representing hospital-acquired infection),
many of the babies who had blood cultures drawn in the
NICU were admitted directly from home or from the
outpatient department after seven days of age. Infants, less
than 30 days of age are also admitted to the NICU rather
than the paediatric ward. Isolates from these admissions
therefore, are more likely to represent community-acquired
rather than hospital- associated late onset infections.
Other studies have reported non-typhoid Salmonella as
the most frequent cause of bloodstream infection in older
children [11,51,52] however the predominant Salmonella
species isolated from the paediatric wards in this study was
Salmonella typhi. It has been suggested that in addition to
poor personal hygiene of caretakers and environmental
contaminations, young children are more susceptible to
Salmonella infection because they possess immature gut
lymphoid tissues and have decreased gastric acidity [11,53].
This finding underscores the need for increased awareness
and knowledge about cleanliness and environmental
sanitation for healthy living in the communities.
As observed from the current study, both the gram-
positive (4% - 25%) and gram–negative (0% - 40%)
bacteria showed very low sensitivity to Ampicillin and
Cotrimoxazole. However the gram negative bacteria
displayed high levels of susceptibility to the third-
generation cephalosporins with the exception of
Pseudomonas aeruginosa. Gentamicin was effective
against Escherichia coli (80%), Acinetobacter (100%) and
the CoNS (72%), but Klebsiella (33.3%), Pseudomonas
(33.3%) and Coagulase positive Staphylococci (42.9%) were
often resistant to Gentamicin.
The recommended empiric antibiotic therapy for EOS
has been Ampicillin and an aminoglycoside, usually
Gentamicin, while in LOS a third-generation cephalosporin
in combination with Ampicillin is used [54,55]. The note-
worthy findings of this study are the susceptibilities of the
GNR to Gentamicin and third-generation cephalosporins.
Many authors report increasing GNR resistance to both
Gentamicin and third-generation cephalosporins in
developing countries which may be related to frequent and
unrestricted use of third-generation cephalosporins
[56-59]. It has been suggested that over-use of third-
generation cephalosporins is also linked to increased risk
of neonatal death [60], increased risk for necrotizing
enterocolitis in low birth-weight infants [61] and increased
risk for invasive candidiasis [62]. Of particular interest are
some Acinetobacter species that have emerged in
Southeast Asia and Africa that are multi-drug resistant
[63,64]. Results from this study shows that the
isolated GNRs are still fairly susceptible to third-
generation cephalosporins. First-line empiric therapy for
rule-out sepsis at the NICU in TTH currently utilizes a
combination drug comprising Ampicillin and Gentamicin
while the third-generation cephalosporins are only
used very selectively, a practice that may reduce risk
for multi-drug resistant bacterial strains.
Conclusions
This review identified Coagulase Negative, Coagulase
Positive Staphylococci, Salmonella and Klebsiella as
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predominant aetiological agents of bloodstream infection
among children at TTH. While both the gram-positive
and gram- negative bacteria showed very low susceptibility
to Ampicillin, Tetracycline and Cotrimoxazole, the GNR
were fairly susceptible to Gentamicin and third-generation
cephalosporins. Further studies to identify risk factors for
developing sepsis and designing interventions to reduce
bloodstream infections in the wards and the communities
should be piloted.
Limitations
Factors such as recent or intrapartum antibiotic use and
requirement for specialized media were not factored into
the inclusion criteria per the design of the study. Data for
this study were obtained over the course of seven months
between July 2011 and January 2012, and therefore seasonal
variations in the frequency of bloodstream infection and
causative microorganisms could not be assessed.
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